University of Saskatchewan

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1907-01-01

Employees: 5K

Market Cap: -

Website: http://www.usask.ca

Clinical Trials

Using Eggshell Calcium to Mitigate Fluorosis in Ethiopia

Not Applicable

Completed

Conditions: Stunting
Development; Delayed, Mental
Zinc Deficiency
Fluoride Poisoning
Fluorosis, Dental
Fluorosis; Skeletal
Hemoglobin
Underweight

Interventions: Behavioral: Promotion of chicken eggs

First Posted Date: 2017-11-28

Last Posted Date: 2020-11-03

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 270

Registration Number: NCT03355222

Locations: 🇪🇹
Hawassa University, Hawassa, Ethiopia

A Pilot Study of IRE for Resectable Pancreatic Cancer

Not Applicable

Withdrawn

Conditions: Pancreatic Adenocarcinoma Resectable

Interventions: Procedure: Irreversible Electroporation

First Posted Date: 2017-11-09

Last Posted Date: 2021-05-06

Lead Sponsor: University of Saskatchewan

Registration Number: NCT03337997

Locations: 🇨🇦
University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Efficacy of a Rinse Containing Sea Salt and Lysozyme on Biofilm and Gingival Health

Not Applicable

Completed

Conditions: Chronic Gingivitis, Plaque Induced
Chronic Gingivitis

Interventions: Other: Sea Salt Mouth Rinse
Other: Standardized Oral Health Practices

First Posted Date: 2017-11-01

Last Posted Date: 2017-11-01

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 30

Registration Number: NCT03329105

Locations: 🇨🇦
College of Dentistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Effect of Vilanterol on Methacholine Challenge Results

Phase 4

Completed

Conditions: Asthma

Interventions: Drug: Vilanterol and Fluticasone Furoate
Drug: Placebos
Drug: Fluticasone Furoate

First Posted Date: 2017-10-19

Last Posted Date: 2018-10-11

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 17

Registration Number: NCT03315000

Locations: 🇨🇦
Asthma Research Lab - University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Tart Cherry Juice for Exercise Performance and Recovery

Not Applicable

Completed

Conditions: Muscle Damage

Interventions: Dietary Supplement: Drink

First Posted Date: 2017-10-18

Last Posted Date: 2018-06-28

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 13

Registration Number: NCT03313388

Locations: 🇨🇦
College of Kinesiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

The Incidence of IV Fluid Over-administration in Pediatric Dental Surgeries When Infusion Pumps Are Employed

Not Applicable

Completed

Conditions: Dental Caries

Interventions: Device: Gravity drip device
Device: Hospira plum pump

First Posted Date: 2017-10-17

Last Posted Date: 2018-10-31

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 103

Registration Number: NCT03312452

Locations: 🇨🇦
University of Saskatchewan, Saskatoon, Saskatchewan, Canada

ECT With Ketamine Anesthesia vs High Intensity Ketamine With ECT Rescue for Treatment-Resistant Depression

Phase 4

Recruiting

Conditions: Ketamine
Treatment Resistant Depression

Interventions: Drug: Ketamine
Procedure: ECT

First Posted Date: 2017-09-05

Last Posted Date: 2023-12-20

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 62

Registration Number: NCT03272698

Locations: 🇨🇦
Royal University Hospital, Saskatoon, Saskatchewan, Canada

Mixed Methods Study Web-based Life Support Decision Aid

Not Applicable

Completed

Conditions: Clinical Decision-Making

Interventions: Behavioral: Web based life support patient decision aid
Behavioral: Decision coaching

First Posted Date: 2017-09-05

Last Posted Date: 2018-10-30

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 120

Registration Number: NCT03271658

Locations: 🇨🇦
Royal University Hospital, Saskatoon, Saskatchewan, Canada

Assessment of Siemens' GoBrain and DotBrain Software

Conditions: Headache

Interventions: Other: MRI Imaging

First Posted Date: 2017-08-31

Last Posted Date: 2017-08-31

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 60

Registration Number: NCT03269539

Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression

Phase 4

Completed

Conditions: Depressive Disorder, Major

Interventions: Drug: Quetiapine 50 MG Extended Release Oral Tablet
Drug: Placebos
Drug: Quetiapine Fumarate XR 150-300 mg

First Posted Date: 2017-07-02

Last Posted Date: 2019-12-04

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 1790

Registration Number: NCT03207438

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy